Full-Thickness Human Skin Models for Congenital Ichthyosis and Related Keratinization Disorders  by Eckl, Katja-Martina et al.
that are also found in hair and esopha-
geal epithelium (Dhouailly et al.,
1989). These findings raise the possibi-
lity that VSIG8 also has an important
role in proper epithelial differentiation
and function in the upper alimentary
tract. The gene is reportedly expressed
at low but genotype-dependent levels
in mouse midbrain (Kozell et al., 2009).
To elucidate the possible roles of VSIG8
in normal function and disease, parti-
cularly in the integument, hundreds of
mouse models for specific human dis-
eases provide invaluable tools for future
studies (Sundberg and King, 1996;
Plikus et al., 2007).
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TO THE EDITOR
In recent years, a variety of recon-
structed human epidermis models and
full-thickness human skin models,
e.g., EpiDerm FT (MatTek, Ashland,
MA) and Phenion Full Thickness Skin
Model (Henkel, Du¨sseldorf, Germany),
were developed. Epidermal barrier
function of artificial skin, as demon-
strated for instance by standardized
penetration assays, was shown to be
highly similar to human skin (Scha¨fer-
Korting et al., 2008; Ackermann et al.,
2010). These results identified recon-
structed human epidermis and full-
thickness skin models as effective
models for the study of normal skin.
Three-dimensional artificial skin mod-
els for disorders of keratinization such
as psoriasis (Tjabringa et al., 2008),
ichthyosis vulgaris and atopic dermati-
tis (Mildner et al., 2010), and Harlequin
ichthyosis (Thomas et al., 2009),
however, were used only rarely and
not characterized in detail. Moreover,
an artificial rat skin model with Tgm1
deficiency (O’Shaughnessy et al.,
2010) and a humanized mouse model
for pachyonychia congenita based
on engraftment of skin equivalents
(Garcı´a et al., 2011) were described
recently. For disorders affecting the
dermis and/or dermal–epidermal junc-
tion zone, specific models for xeroder-
ma pigmentosum (Bernerd et al., 2005)
and dystrophic epidermolysis bullosa
(Gache et al., 2004) were presented.
To develop organotypic systems that
can be easily adapted to several dis-
orders of keratinization, we have estab-
lished and characterized full-thickness
human skin models for autosomal
recessive congenital ichthyosis (ARCI)
in this study. ARCI can be causedAbbreviations: ARCI, autosomal recessive congenital ichthyosis; SC, stratum corneum
1938 Journal of Investigative Dermatology (2011), Volume 131
K-M Eckl et al.
Human Skin Models for Congenital Ichthyosis
by mutations in the genes TGM1,
ALOX12B, ALOXE3, NIPAL4, CYP4F22,
and ABCA12, and in other, still un-
known, genes. The disease models,
based on the protein deficiency respon-
sible for the specific disorder, were
characterized on biochemical, histo-
logical, and genetic level for the typical
features of the disease.
Our full-thickness human skin mod-
els were prepared using normal human
epidermal keratinocytes and dermal
fibroblasts, isolated from skin speci-
mens of healthy donors aged 5–71 years
(skin types II–III). Cells were isolated
following standard procedures (Leigh
and Watt, 1994) after obtaining written,
informed consent of the probands and
institutional approval in accordance
with the Helsinki Guidelines. Keratino-
cytes were cultured from passage 2 in
serum-free, defined culture medium
(KGM, Lonza, Verviers, Belgium) with-
out feeder cells. Model generation was
modified from the protocol of Mildner
et al. (2006), using 0.1106 fibro-
blasts per ml of collagen matrix
and 1.0–1.18 106 keratinocytes per
cm2 growth area in a 3-mm filter
tissue culture insert (BD Biosciences,
Heidelberg, Germany). Bovine collagen
I, fibroblasts, and serum were mixed
and 2.5 ml of this solution was poured
into each filter insert; medium was
added after incubation at 37 1C for
2 hours. Keratinocytes were seeded
onto the matrix in a total volume of
1 ml medium per insert. After 24 hours,
the system was raised to the air–liquid
interface, medium was changed to
keratinocyte-conditioned medium as
differentiation medium, and models
were grown for 8 days. Fibroblasts and
keratinocytes were used from the same
donor in a particular experiment and
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Figure 1. Characterization of full-thickness human skin models. (a) Hematoxylin and eosin staining of full-thickness skin models prepared with (i) fibroblasts
and keratinocytes, each derived from different donors, leading to massive hyperkeratosis and disturbed epidermal structure; (ii) differentiation medium for
models supplemented with 10 ng per ml transforming growth factor-b1, epidermal differentiation was disturbed, and stratum corneum (SC) enlarged; (iii–iv)
keratinocyte-conditioned medium (KCM) as differentiation medium. These models showed a regular differentiation and a defined but constantly thin SC.
Bars¼ 100 mm. (b) Immunofluorescence staining against markers of epidermal differentiation such as (i) filaggrin and (ii) keratin 10 in models raised in KCM,
showing clear signals in differentiating keratinocytes of the full-thickness human skin models; expression of (iii) integrin-b1 and (iv) collagen IV, indicating a
well-established and constant basement membrane zone. Nuclear stain was done with 4’,6-diamidino-2-phenylindole. Bars¼75 mm.
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matched for passage numbers. Cells
were not used later than passages
4 and 6 for keratinocytes and fibro-
blasts, respectively. We did not see
clear differences in the models when
using cells derived from infant or adult
donors, besides the reduced prolifera-
tion rates of cells from elderly probands
in early passages, or between cells from
foreskin and other parts of the skin
including cells isolated from biopsy
specimens.
ARCI, like several other disorders of
keratinization, is characterized by
marked barrier dysfunction. We have
first used various approaches for the
generation of full-thickness normal skin
models and analyzed these with parti-
cular respect to the development of
a regular epidermal morphology and a
functional barrier. The use of fibroblasts
and keratinocytes obtained from differ-
ent donors for a single model resulted
in pronounced hyperkeratosis and a
disturbed epidermal layer formation
(Figure 1ai; Lampert, 1985). As im-
paired barrier function in ARCI might
result in a massive cell turnover in
the dividing layers of the epidermis
(Williams, 1992), we supplemented
our differentiation medium with 10 ng
per ml transforming growth factor-b1
to inhibit proliferation, induce differen-
tiation, and promote basement mem-
brane zone integrity. Surprisingly,
we found the stratum corneum (SC)
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Figure 2. Analysis of human skin models for congenital ichthyosis obtained after gene knockdown. (a) Relative expression of downregulated genes analyzed
by quantitative real-time RT-PCR. Expression was clearly reduced both at days 1 and 9, indicating effective and stable knockdown. (b) Expression of downregulated
genes analyzed by immunofluorescence staining in skin equivalents. KD, model with knockdown of ALOXE3, ALOX12B, and TGM1, respectively; WT, wild-type
model. Bars¼75mm. (c) Full-thickness human skin models with knockdown of ALOX12B (i–iii), ALOXE3 (iv–vi), and TGM1 (vii–ix) stained for markers of epidermal
differentiation and basement membrane zone (BMZ) integrity. Expression of filaggrin (FLG; i, iv, vii) was reduced in the stratum corneum, but expression of keratin 10
(KRT10; ii, v, viii) was normal. Staining for integrin-b1 (iii, ix) and collagen IV (vi) showed clear signals. Bars¼ 75mm. (d) Quantification of FLG expression in models
with knockdown of ALOX12B, ALOXE3, and NIPAL4. (e) Lucifer yellow (LY) penetration assay. Models with knockdown of ALOX12B (ii, v, viii) and ALOXE3 (iii, vi,
ix) showed clear epidermal barrier defect in contrast to control model (i, iv, vii). Bars¼ 75mm. DAPI, 4’,6-diamidino-2-phenylindole.
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massively thickened, the epidermis
enlarged, the overall architecture of
the models disturbed, as basal cells
were flattened, differentiating keratino-
cytes showed an early flattening, and
single layers were hardly discernable
(Figure 1aii). To improve the model
architecture and reduce unspecific
thickening of the SC, we changed
culture conditions during the air-lift
phase using a medium based on
DMEM:F12 with 10% bovine serum,
first described by Allen-Hoffmann and
Rheinwald (1984) and based on earlier
findings of effects of EGF, cholera toxin,
and hydrocortisone (Rheinwald and
Green, 1975; Green, 1978). Analysis
confirmed a well-established basement
membrane zone, upright basal kerati-
nocytes and clearly distinguishable
epidermal layers, terminal differentia-
tion of keratinocytes, and a discrete SC
(Figure 1aiii–iv). The regular differentia-
tion of keratinocytes and the constant
presence of basal keratinocytes and
basement membrane zone proteins
were confirmed by immunofluores-
cence staining of marker proteins,
such as filaggrin, keratin 10, collagen
IV, and integrin-b1 (Figure 1b).
To induce the development of ARCI
in full-thickness human skin models,
we transfected normal human keratino-
cytes not older than passage 3 with
small interfering RNA against TGM1,
ALOX12B, ALOXE3, NIPAL4, CYP4F22,
and ABCA12, respectively. A set of three
small interfering RNA (740 pmol each)
for each gene and 50ml Lipofectamine
2000 were used in a T75 flask (Stealth
Select RNAi, Invitrogen, Paisley, UK).
Quantitative RT-PCR with RNA isolated
24 hours and 9 days after knockdown
using the housekeeping genes RPS18,
ACTB, and 18S RNA for standardization
demonstrated a specific reduction of
gene expression, which was stable over
time (Figure 2a). Gene expression was
nearly normal after transfection with
non-specific small interfering RNA. The
loss of the target protein following
the specific knockdown was further
demonstrated by immunofluorescence
analysis of diseased skin equivalents
compared with skin equivalents with
normal keratinocytes (Figure 2b). ARCI
models showed a massive thickening of
the SC, an earlier flattening of keratino-
cytes, and a denser, more compact
structure of the epidermis in accordance
with the histopathology of ARCI (Sup-
plementary Figure S1 online). Expression
of collagen IV and integrin-b1 were well
detectable (Figure 2ciii, vi, ix). Synthesis
of epidermal differentiation markers
such as keratin 10 was visible but
broadened and occurred earlier in dis-
ease models (Figure 2cii, v, viii). Filag-
grin was also present (Figure 2ci, iv, vii)
but clearly reduced in various ARCI
models, which is supposed to be an
effect of the disturbed epidermal differ-
entiation and to contribute to the
reduced barrier activity (Figure 2d).
As the function of the epidermal
barrier is often crucial for studies
of ARCI and other keratinization dis-
orders, we then assessed the outside–
in barrier using a penetration assay
with lucifer yellow (Epp et al., 2007).
A sterile stainless-steel ring (1-cm inner
diameter) was placed on top of the
epidermis model, and 1 mM lucifer
yellow was added and washed off after
1 hour incubation at 37 1C. Application
of the dye to the epidermis revealed
a clear barrier defect in the disease
models. Lucifer yellow penetrated
through the SC and all layers of the
epidermis of the knockdown models
but did not infiltrate into the epidermis
in controls (Figure 2e). Although the
barrier function is influenced by various
factors in vivo, our findings in the
diseased skin models clearly display
the basic barrier defect in certain
monogenic keratinization disorders, as
we have recently demonstrated, for
instance, in autosomal recessive gen-
eralized peeling skin disease, which
can be caused by mutations in the gene
for corneodesmosin (Oji et al., 2010).
In total, we have generated more
than 500 full-thickness skin models for
healthy and diseased skin until now.
In all, 200 of these underwent detailed
analysis for skin penetration following
international guidelines developed
by the Organisation for Economic
Co-operation and Development and Eur-
opean Centre for the Validation of
Alternative Methods (details will be
published elsewhere). Thus, the system
presented here for ARCI is a versatile full-
thickness human skin model; it can be
implemented for the study of various
monogenic keratinization disorders char-
acterized by deficiency of a specific
protein and is independent of allelic
heterogeneity. The skin models are parti-
cularly useful for the analysis of epider-
mal barrier function, which is disturbed
in several of these diseases and relevant
to complex phenotypes such as atopy.
It can be further used as an alternative to
animals to validate the transfer of re-
agents into the epidermis and the effects
of newly developed drugs in the skin.
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AKT Has an Anti-Apoptotic Role in ABCA12-Deficient
Keratinocytes
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TO THE EDITOR
Harlequin ichthyosis (HI) is a hereditary
skin disorder characterized by severe
hyperkeratosis and impaired skin barrier
function (Moskowitz et al., 2004; Akiya-
ma et al., 2005). We have identified the
ATP-binding cassette transporter A12
(ABCA12) as the causative gene of HI
and, furthermore, demonstrated that
ABCA12 is essential for keratinocyte lipid
transport (Akiyama et al., 2005; Yanagi
et al., 2008). Loss of ABCA12 function
causes lipid transport to be defective in
keratinocytes of the upper spinous and
granular layers, resulting in the deposi-
tion of numerous intracellular lipid dro-
plets and malformation of intercellular
lipid layers (Akiyama et al., 2005; Yanagi
et al., 2010). Recently, we have shown
that gangliosides accumulate in the differ-
entiated keratinocytes of HI patients
(Mitsutake et al., 2010). On the basis of
the evidence that lipid accumulation is
involved in keratinocyte apoptosis (Wang
et al., 2001; Uchida et al., 2010), we
investigated apoptotic and anti-apoptotic
parameters in skin samples from HI
patients and Abca12/ HI model mice.
We studied the skin of two HI
patients and that of Abca12/ mice.
The ABCA12 mutations of the two HI
patients have been previously reported:
one patient has the homozygous splice
acceptor site mutation c.3295-2A4G
and the other has the homozygous
nonsense mutation p.Arg434X (Akiya-
ma et al., 2005). The procedure for
generating Abca12/ mice, the estab-
lishment of primary-cultured keratino-
cytes, immunofluorescence staining,
immunoblotting, and real-time reverse
transcriptase PCR analysis has been
previously described (Yanagi et al.,
2008, 2010). First, we investigated the
apoptosis of HI patient epidermis by
hematoxylin–eosin stain and TUNEL
assay (In situ Apoptosis Detection Kit,
Takara Bio, Otsu, Japan). In the HI
patients, the nuclei of the granular-layer
keratinocytes were condensed (Figure
1b) and they show positive for TUNEL
labeling (Figure 1d), although apoptotic
nuclei are rare in the normal human
epidermis (Figure 1a, c). The histo-
pathological findings and results of
TUNEL staining of the Abca12/ mice
were similar to those in the skin of the
HI patients (Figure 1f and h). TUNEL
staining in the epidermis of 18.5-day
embryos indicated that the apoptosis of
keratinocytes started during fetal skin
development (Figure 1j).
We assessed the degree of AKT
activation of Abca12/ skin and kera-
tinocytes using anti-AKT antibody
#4691 and anti-phosphorylated AKT
(Ser473) #4060 antibody (Cell Signal-
ing, Danvers, MA). By immunoblot
analysis, differentiated primary-cul-
tured keratinocytes and the epidermis
of Abca12/ mice showed higher
expression levels of Ser-473 phosphory-
lated AKT than those of the control
wild-type mice (Figure 1o). Immuno-
fluorescence staining detected phos-
phorylated AKT in the upper granular-
layer keratinocytes of the Abca12/
mouse skin (Figure 1l), but not in the
skin of control wild-type mouse (Figure
1k). Cell proliferation was assessed by
Ki-67 immunofluorescence (Figure 1).
Ki-67 stain was similar in the wild-type
and the Abca12/ samples, indicating
that the granular-layer keratinocytes
of the Abca12/ neonatal mice
showed no excessive cell proliferation.
To clarify whether AKT activation has
Abbreviations: ABCA12, ATP-binding cassette transporter A12; HI, harlequin ichthyosis; PPAR,
peroxisome proliferator-activated receptor; RXR, retinoid X receptor
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